Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3728785012 | Acamprosate only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3728786013 | Product containing only acamprosate (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2848251000001116 | Acamprosate (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2848261000001118 | Acamprosate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acamprosate | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Acamprosate | Is a | Product containing acamprosate | true | Inferred relationship | Existential restriction modifier | ||
| Acamprosate | Has active ingredient | Acamprosate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Acamprosate | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only acamprosate in oral dose form (medicinal product form) | Is a | True | Acamprosate | Inferred relationship | Existential restriction modifier | |
| Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet | Is a | True | Acamprosate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR